This is a Validated Antibody Database (VAD) review about human IGFBP2, based on 8 published articles (read how Labome selects the articles), using IGFBP2 antibody in all methods. It is aimed to help Labome visitors find the most suited IGFBP2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IGFBP2 synonym: IBP2; IGF-BP53; insulin-like growth factor-binding protein 2; IGF-binding protein 2; insulin-like growth factor binding protein 2, 36kDa

Abcam
rabbit monoclonal (EPR3380(2))
  • immunohistochemistry - paraffin section; human; loading ...; fig 2b
Abcam IGFBP2 antibody (Abcam, ab109284) was used in immunohistochemistry - paraffin section on human samples (fig 2b). Oncotarget (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (G-1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to develop and characterize patient-derived primary xenografts to a model of muscle invasive bladder cancer, Santa Cruz Biotechnology IGFBP2 antibody (Santa Cruz, sc-365368) was used in immunohistochemistry - paraffin section on human samples at 1:100. Oncotarget (2015) ncbi
mouse monoclonal (C-10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology IGFBP2 antibody (Santa Cruz Biotechnology, sc-25285) was used in immunohistochemistry - paraffin section on human samples (fig 4b) and in western blot on human samples (fig 2c). Oncotarget (2014) ncbi
R&D Systems
mouse monoclonal (92326)
  • western blot; human; loading ...; fig 2b
R&D Systems IGFBP2 antibody (R&D, MAB6741) was used in western blot on human samples (fig 2b). Oncotarget (2016) ncbi
Proteintech Group
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 4
In order to elucidate how polycystin-1 and -2 traffic to cilia, Proteintech Group IGFBP2 antibody (Proteintech, 11065-3-AP) was used in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2014) ncbi
Cell Signaling Technology
rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology IGFBP2 antibody (Cell Signaling, 3922) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology IGFBP2 antibody (CST, 3922) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology IGFBP2 antibody (Cell Signaling Technology, 3922) was used in western blot on human samples . Cell Syst (2017) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:200; fig 3
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology IGFBP2 antibody (Cell-Signaling Technologies, 3922) was used in immunohistochemistry on human samples at 1:200 (fig 3) and in western blot on human samples at 1:1000 (fig 5). PLoS Pathog (2015) ncbi
Articles Reviewed
  1. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  2. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  3. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  4. Hawsawi Y, Humphries M, Wright A, Berwick A, Shires M, Al Kharobi H, et al. Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro. Oncotarget. 2016;7:32129-43 pubmed publisher
  5. Pickard A, McDade S, McFarland M, McCluggage W, Wheeler C, McCance D. HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures. PLoS Pathog. 2015;11:e1004988 pubmed publisher
  6. Jäger W, Xue H, Hayashi T, Janssen C, Awrey S, Wyatt A, et al. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. Oncotarget. 2015;6:21522-32 pubmed
  7. Kim H, Xu H, Yao Q, Li W, Huang Q, Outeda P, et al. Ciliary membrane proteins traffic through the Golgi via a Rabep1/GGA1/Arl3-dependent mechanism. Nat Commun. 2014;5:5482 pubmed publisher
  8. Martino Echarri E, Fernández Rodríguez R, Bech Serra J, Plaza Calonge M, Vidal N, Casal C, et al. Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1. Oncotarget. 2014;5:4295-304 pubmed